The purpose of this expert review is to discuss the impact of nanotechnology in the treatment
of the major health threats including cancer, infections, metabolic diseases, autoimmune …

Since the introduction to the Swiss market in 1997, Crucell (former Berna Biotech Ltd.), has
sold over 41 million doses worldwide of the virosomal adjuvanted influenza vaccine …

Cellular immune responses to influenza virus infection and influenza virus vaccination have
not been rigorously characterized. We quantified the effector and memory B-cell responses …

Background Seasonal influenza immunization programs vary widely across jurisdictions. In
Canada, some provinces offer universal programs while others target specific population …

Background: Two systematic reviews evaluating influenza vaccine efficacy in healthy
children have recently been published. Although quantitative summary estimates were …

Objective Vaccination will be instrumental in controlling the COVID-19 pandemic, and
vaccination of children will be necessary to achieve herd immunity. Given that children with …

Background Influenza is a major cause of respiratory illness in young children. Assessing
the impact of infection on children and the community is required to guide immunisation …

BACKGROUND: The seasonal influenza vaccination programme in England targets
individuals over 65years old and in clinical risk groups. METHODS: A model of influenza …

Background In July 2000, the province of Ontario, Canada, initiated a universal influenza
immunization program (UIIP) to provide free seasonal influenza vaccines for the entire …

This cross-sectional study of 340 obstetrics/gynecology, 123 neonatology, and 244 pediatric
health care workers (HCWs) was designed to evaluate compliance with recommendations …